This is an old revision of this page, as edited by Testem (talk | contribs) at 09:31, 11 March 2012 (added uk legal status). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 09:31, 11 March 2012 by Testem (talk | contribs) (added uk legal status)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Pharmaceutical compoundIdentifiers | |
---|---|
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.162.251 |
Chemical and physical data | |
Formula | C17H19N |
Molar mass | 237.339 g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(verify) |
2-Diphenylmethylpyrrolidine (Desoxy-D2PM), also known as 2-benzhydrylpyrrolidine, is a stimulant psychoactive drug. It is the 4-dehydroxylated structural analogue of diphenylprolinol (D2PM), and is also similar in structure to desoxypipradrol (2-DPMP), both of which act as norepinephrine-dopamine reuptake inhibitors (NDRIs). Like D2PM and 2-DPMP, Desoxy-D2PM is sold as a designer drug, and has been used in the manufacture of legal highs. It has been marketed under the names A3A New Generation, A3A Methano, and Green Powder, and has been reported to cause hallucinations, violent behavior, dilated pupils, tachycardia, and high blood pressure.
Desoxy-D2PM has two enantiomers which are used industrially in their purified form for resolution of chiral reagents during chemical synthesis.
As of the 4th November 2010, the UK Home Office announced a ban on the importation of 2-DPMP, following a recommendation from the ACMD. It will become a class B drug on the 28th March.Cite error: The <ref>
tag has too many names (see the help page).
References
- http://www.ncbi.nlm.nih.gov/pubmed/22055832
- http://www.droganews.it/pubdownload.php?id=2472
- http://ewsd.wiv-isp.be/Other%20information%20on%20new%20psychoactive%20substances/Desoxy-D2PM/Report_UK_Dec%202010_Green%20Powder%20called%20A3A%20Methano.pdf
- Bertelsen S, Halland N, Bachmann S, Marigo M, Braunton A, Jørgensen KA. Organocatalytic asymmetric α-bromination of aldehydes and ketones. Chem. Commun. 2005, 4821-4823doi:10.1039/b509366j
- Import ban on psychoactive drug, UK Home Office
- "The Misuse of Drugs Act 1971 (Amendment) Order 2012" (PDF). UK Home Office. 2012-01-27. Retrieved 2012-03-11.
This drug article relating to the nervous system is a stub. You can help Misplaced Pages by expanding it. |